Catalyst Pharmaceuticals (CPRX)
2.64
+0.06 +2.33%
NASDAQ
Apr 25, 20:00
Delayed 2m
USD
View All Key Stats
CPRX Key Stats
| Income Statement | |
| Revenue (TTM) | -- |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -0.21 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -18.41M |
| Profitability | |
| Gross Profit Margin (Quarterly) | -- |
| Profit Margin (Quarterly) | -- |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | Upgrade |
| Price and Valuation | |
| Market Cap | 270.75M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | -- |
| PE Ratio (TTM) | -- |
| Price to Book Value | 3.344 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | Upgrade |
| Free Cash Flow (Quarterly) | -4.030M |
| Return on Equity (TTM) | Upgrade |
View All CPRX News
CPRX News
-
WireHeadlineTime (ET)
-
Globe Newswire04/24 08:03
-
Globe Newswire04/20 08:10
-
SA Breaking News04/19 11:05
-
MT Newswires04/19 10:25
-
Globe Newswire04/19 08:03
-
SA Breaking News04/04 12:41
-
SA Breaking News04/04 11:00
-
Yahoo03/29 14:20
-
MT Newswires03/29 13:44
-
SA Breaking News03/29 08:42
View All Events
CPRX Events
| Date | Type | Description |
|---|---|---|
| 05/11/2018 | Misc | Catalyst Pharmaceuticals Inc First Quarter Earnings Conference Call in 2018 |
| 05/10/2018 | Earnings | Catalyst Pharmaceuticals Inc First Quarter Earnings Results in 2018 |
| 03/14/2018 | Earnings | Catalyst Pharmaceuticals Inc Fourth Quarter Earnings in 2017 Release |
| 03/14/2018 08:30 EDT | Misc | Catalyst Pharmaceuticals Inc Fourth Quarter Earnings Conference Call in 2017 |
| 11/09/2017 08:30 EST | Misc | Catalyst Pharmaceuticals Inc Third Quarter Earnings Conference Call in 2017 |
| 11/08/2017 | Earnings | Catalyst Pharmaceuticals Inc Third Quarter Earnings in 2017 Release |
| 08/10/2017 08:30 EDT | Misc | Catalyst Pharmaceuticals Inc Second Quarter Earnings Conference Call in 2017 |
| 08/09/2017 | Earnings | Catalyst Pharmaceuticals Inc Second Quarter Earnings Results in 2017 |
| 05/25/2017 | Misc | Catalyst Pharmaceuticals Inc Annual General Meeting in 2016 |
| 05/11/2017 08:30 EDT | Misc | Catalyst Pharmaceuticals Inc First Quarter Earnings Conference Call in 2017 |
CPRX Fundamentals
Income Statement View Statement
CPRX Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
CPRX One Page Reports
- One Page Report Download
CPRX Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 2.64 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Edit
Profile
- URL: http://www.catalystpharma.com
- Investor Relations URL: http://ir.catalystpharma.com/
- HQ State/Province: Florida
- Sector: Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Equity Style: Small Cap/Blend
- Next Earnings Release: May. 10, 2018
- Last Earnings Release: Mar. 14, 2018
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Catalyst Pharmaceuticals Inc is a biopharmaceutical company. The company is engaged in the development and commercialization of therapies for people with rare debilitating diseases, chronic neuromuscular and neurological diseases.
CPRX Excel Add-In Codes
- Name: =YCI("CPRX","name")
- Description: =YCI("CPRX","description")
- Sector: =YCI("CPRX","sector")
- Industry: =YCI("CPRX","industry")
- Est. Current Fiscal Year End: =YCI("CPRX","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other CPRX Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- CPRX Tweets Stocktwits
Advertisement
